Drug ID: | NPD4859 |
Drug Name: | NK-314 |
Molecular Formula: | C22H17NO4 |
Canonical SMILES: | COC1=CC=c2c(C1=O)c1CCC[n+]1c1c2ccc2c1cc1c(c2)OCO1 |
Standard InCHI: | InChI=1S/C22H17NO4/c1-25-17-7-6-13-14-5-4-12-9-18-19(27-11-26-18)10-15(12)21(14)23-8-2-3-16(23)20(13)22(17)24/h4-7,9-10H,2-3,8,11H2,1H3/p+1 |
Standard InCHIKey: | PPIAOPULFFWFNC-UHFFFAOYSA-O |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB011444 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 360.12 |
ALogP | -1.9644 |
MLogP | 3.33 |
XLogP | 2.674 |
HDA | 2 |
HBD | 1 |
Rotatable Bonds | 2 |
TPSA | 49.2 |
RO5 Violation | 0 |